MENU
BTSG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BTSG stock forecast, quote, news & analysis

BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients... Show more

BTSG
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for BTSG with price predictions
Sep 11, 2026

BTSG in downward trend: 10-day moving average moved below 50-day moving average on August 07, 2026

The 10-day moving average for BTSG crossed bearishly below the 50-day moving average on August 07, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 3 of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 75%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 23 of 31 cases where BTSG's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 74%.

The Momentum Indicator moved below the 0 level on September 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BTSG as a result. In 27 of 43 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BTSG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.

The Aroon Indicator for BTSG entered a downward trend on September 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for BTSG just turned positive on August 26, 2026. Looking at past instances where BTSG's MACD turned positive, the stock continued to rise in 20 of 21 cases over the following month. The odds of a continued upward trend are 90%.

Following a +3.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where BTSG advanced for three days, in 163 of 182 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. BTSG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 48 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.672) is normal, around the industry mean (7.171). P/E Ratio (52.438) is within average values for comparable stocks, (44.460). BTSG's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.499). Dividend Yield (0.000) settles around the average of (0.045) among similar stocks. P/S Ratio (0.911) is also within normal values, averaging (5.983).

The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BTSG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 2.75B. The market cap for tickers in the group ranges from 708 to 42.48B. VEEV holds the highest valuation in this group at 42.48B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was -3%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 19%. ACON experienced the highest price growth at 11%, while OMDA experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was -2%. For the same stocks of the Industry, the average monthly volume growth was -32% and the average quarterly volume growth was -52%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 75
Price Growth Rating: 54
SMR Rating: 86
Profit Risk Rating: 97
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
BTSG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Details
Industry
N/A
Address
805 N. Whittington Parkway
Phone
+1 502 394-2100
Employees
23500
Web
https://www.brightspringhealth.com
BTSG in downward trend: 10-day moving average moved below 50-day moving average on August 07, 2026